Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine  Joint Metastasis Research Society-AACR Conference on Metastasis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 30, 830-833, March 1, 1970]
© 1970 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fukuda, S.
Right arrow Articles by Yamamoto, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fukuda, S.
Right arrow Articles by Yamamoto, N.

Effect of ß-Propiolactone on Bacteriophages and Salmonella typhimurium1

Shizuo Fukuda and Nobuto Yamamoto

Fels Research Institute and Department of Microbiology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140

Low concentrations of ß-propiolactone (BPL) inactivated Salmonella typhimurium strains and the bacteriophage P22. When ultraviolet light-sensitive (hcr-) mutants, recombination-deficient (rec-) mutants, and wild type were treated with 0.05% BPL, rec- mutants were inactivated drastically, hcr- mutants were inactivated very rapidly, and wild type were inactivated slowly. BPL induced the prophage P221 from wild type and hcr- mutants. However, no prophage induction from rec- mutants by BPL was observed. When BPL-damaged bacteriophage P22 was assayed simultaneously on hcr- mutants, rec- mutants, and wild type, it was found that survival of P22 on wild type was slightly higher than that on rec>- and hcr- mutants. This observation suggests that the BPL-damaged bacteriophage genome was repaired, presumably through the combined action of bacterial excision, bacterial recombination, and phage recombination enzymes.

When a clear plaque-forming mutant (c2) of P22 phage was treated with BPL and assayed on hosts either lysogenic or nonlysogenic for P221b, c+ plaques were observed among survivors on the P221b lysogen, whereas no c+ plaques were found on the nonlysogens. No significant increase in c+ plaques was found in survivors on P221b lysogens of the rec- strain.

It is concluded that BPL acts directly on phage DNA and results in inactivation, repair, and recombination.

1 Supported in part by grants from the National Science Foundation (NSF-GB-8503), and USPHS (NIH-AI-06429 and NIH-CA-10439).

Received 7/ 1/69. Accepted 9/10/69.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1970 by the American Association for Cancer Research.